2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Pham Quang X | CEO | 200,000 | Oct 28, 2025 |
| Cole Jeffrey Scott | — | 150,000 | Apr 3, 2024 |
| Losordo Douglas W | — | 150,000 | Jan 19, 2024 |
| Zelenkofske Steven | — | 100,000 | Jan 19, 2024 |
| Murphy John Raymond | Director | 100,000 | Jan 19, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Dec 31, 2025 | Szot Matthew K | CFO | Sell | 11.3 | -9,933 | -100.00% | ✓ | $69.2K |
| Dec 2, 2025 | Dec 3, 2025 | Golden Lee Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2025 | Golden Lee Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 24, 2025 | Oct 28, 2025 | Szot Matthew K | CFO | Sell | 10.0 | -3,600 | -26.60% | ✓ | $50.4K |
| Oct 24, 2025 | Oct 28, 2025 | Pham Quang X | CEO | Sell | 51.3 | -2,444 | -0.61% | ✓ | $34.2K |
| Oct 9, 2025 | Oct 14, 2025 | Szot Matthew K | CFO | Sell | 18.8 | -3,493 | -20.52% | ✓ | $49K |
| Oct 9, 2025 | Oct 14, 2025 | Pham Quang X | CEO | Sell | 47.5 | -3,600 | -0.90% | ✓ | $50.7K |
| Oct 6, 2025 | Oct 7, 2025 | Szot Matthew K | CFO | Sell | 52.5 | -107 | -0.62% | ✓ | $1.5K |
| Oct 2, 2025 | Oct 3, 2025 | Pham Quang X | CEO | Sell | 55.0 | -500 | -0.12% | ✓ | $7.1K |
| Sep 29, 2025 | Oct 1, 2025 | Szot Matthew K | CFO | Sell | 32.5 | -1,800 | -9.51% | ✓ | $25.2K |
| Sep 29, 2025 | Oct 1, 2025 | Pham Quang X | CEO | Sell | 52.5 | -1,300 | -0.32% | ✓ | $18.2K |
| Sep 24, 2025 | Sep 26, 2025 | Szot Matthew K | CFO | Sell | 22.5 | -12,400 | -39.57% | ✗ | $174.2K |
| Sep 24, 2025 | Sep 26, 2025 | Pham Quang X | CEO | Sell | 22.5 | -9,371 | -2.27% | ✗ | $131.8K |
| Aug 27, 2025 | Aug 29, 2025 | Szot Matthew K | CFO | Sell | 26.3 | -2,000 | -6.00% | ✗ | $28K |
| Aug 27, 2025 | Aug 29, 2025 | Pham Quang X | CEO | Sell | 22.5 | -5,029 | -1.20% | ✗ | $70.4K |
| Jan 23, 2025 | Mar 24, 2025 | Pham Quang X | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 6, 2025 | Ferguson James J. III | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Ferguson James J. III | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 23, 2025 | Jan 24, 2025 | MURPHY JOHN RAYMOND | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | WILSON GLYNN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | Zelenkofske Steven | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | Cole Jeffrey Scott | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | Szot Matthew K | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | Pham Quang X | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 24, 2025 | Lisicki Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 10, 2024 | Apr 10, 2024 | Pham Quang X | CEO | Neutral | 37.5 | -50,000 | -0.79% | ✗ | - |
| Apr 2, 2024 | Apr 3, 2024 | Cole Jeffrey Scott | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2024 | Cole Jeffrey Scott | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 23, 2023 | Feb 12, 2024 | Pham Quang X | CEO | Neutral | 27.5 | -85,000 | -1.33% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | Zelenkofske Steven | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | MURPHY JOHN RAYMOND | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | Lisicki Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | Pham Quang X | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | Szot Matthew K | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | WILSON GLYNN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 18, 2024 | Jan 19, 2024 | LOSORDO DOUGLAS W | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2023 | Oct 6, 2023 | MURPHY JOHN RAYMOND | Director | Buy | 83.8 | +20,000 | 3.36% | ✗ | $14K |
| Sep 5, 2023 | Sep 6, 2023 | Pham Quang X | CEO | Buy | 68.8 | +40,000 | 0.63% | ✗ | $36.2K |
| Sep 1, 2023 | Sep 5, 2023 | Pham Quang X | CEO | Buy | 82.5 | +70,000 | 1.11% | ✗ | $63.9K |
| Jul 23, 2023 | Jul 24, 2023 | Lisicki Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2023 | Lisicki Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 31, 2023 | LOSORDO DOUGLAS W | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 21, 2023 | Mar 22, 2023 | MURPHY JOHN RAYMOND | Director | Buy | 78.8 | +10,000 | 1.71% | ✗ | $13.9K |
| Mar 16, 2023 | Mar 16, 2023 | MURPHY JOHN RAYMOND | Director | Buy | 83.8 | +20,000 | 3.60% | ✗ | $33.4K |
| Feb 10, 2023 | Feb 13, 2023 | Pham Quang X | CEO | Neutral | 60.0 | +25,000 | 0.40% | ✗ | - |
| Jan 24, 2023 | Jan 24, 2023 | WILSON GLYNN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2023 | Jan 24, 2023 | Szot Matthew K | CFO | Neutral | 90.0 | +50,000 | 11.11% | ✗ | - |
| Jan 24, 2023 | Jan 24, 2023 | MURPHY JOHN RAYMOND | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 19, 2023 | Zelenkofske Steven | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 19, 2023 | WILSON GLYNN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 19, 2023 | Szot Matthew K | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 19, 2023 | Pham Quang X | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 19, 2023 | MURPHY JOHN RAYMOND | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 19, 2023 | LOSORDO DOUGLAS W | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |